Phase I trial of BTT 1023 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2008
At a glance
- Drugs Timolumab (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions
- 18 Jun 2008 Results reported in a BioTie Therapies Corp media release
- 01 Jun 2008 Status changed from not yet recruiting to completed.
- 25 Apr 2008 Results are expected during the second quarter of 2008, according to a media release from Biotie Therapies.